Oragenics Past Earnings Performance

Past criteria checks 0/6

Oragenics has been growing earnings at an average annual rate of 3.6%, while the Biotechs industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 50.2% per year.

Key information

3.6%

Earnings growth rate

37.3%

EPS growth rate

Biotechs Industry Growth11.5%
Revenue growth rate50.2%
Return on equity-771.8%
Net Margin-98,219.7%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Oragenics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A64 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 240-2060
31 Dec 230-2150
30 Sep 230-1050
30 Jun 230-1240
31 Mar 230-1340
31 Dec 220-1440
30 Sep 220-1450
30 Jun 220-1540
31 Mar 220-1550
31 Dec 210-1650
30 Sep 210-185-19
30 Jun 210-186-15
31 Mar 210-265-4
31 Dec 200-2650
30 Sep 200-26422
30 Jun 200-25421
31 Mar 200-17413
31 Dec 190-16412
30 Sep 190-15411
30 Jun 190-15410
31 Mar 190-1347
31 Dec 180-1146
30 Sep 180-1045
30 Jun 180-834
31 Mar 180-734
31 Dec 170-734
30 Sep 170-845
30 Jun 170-844
31 Mar 170-845
31 Dec 160-845
30 Sep 160-844
30 Jun 160-834
31 Mar 160-1339
31 Dec 150-1239
30 Sep 150-1138
30 Jun 150-1037
31 Mar 151-533
31 Dec 141-633
30 Sep 141-8510
30 Jun 141-16710
31 Mar 141-16710
31 Dec 131-1689
30 Sep 131-1563
30 Jun 131-863

Quality Earnings: 0A64 is currently unprofitable.

Growing Profit Margin: 0A64 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0A64 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.6% per year.

Accelerating Growth: Unable to compare 0A64's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A64 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (3%).


Return on Equity

High ROE: 0A64 has a negative Return on Equity (-771.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.